https://ijmri.de/index.php/jmsi
volume 4, issue 4, 2025
38
ONCOLOGICAL DISEASES AND DIAGNOSTIC METHODS
Shukulloyeva Nafosat Qahramon kizi
Obstetric Complex of Angren City, Laboratory Physician
Email: nafosat.shukulloyeva@email.com
Annotation:
This article analyzes the most prevalent types of oncological diseases, the main
contributing factors to their development, and the modern diagnostic technologies used to detect
them. Early detection, particularly through screening methods, artificial intelligence, and liquid
biopsy, plays a crucial role in improving patients’ life expectancy and quality of life.
Keywords:
Oncology, diagnostics, artificial intelligence, liquid biopsy, screening, cancer
Introduction
In the past decade, global trends related to cancer show that increased life expectancy,
environmental pollution, unhealthy diets, smoking, and alcohol consumption significantly impact
the development of cancer. Especially in low- and middle-income countries, cancer incidence is
rising rapidly. According to UN forecasts, by 2040, cancer cases may reach 27.5 million globally.
Literature Review
Numerous international studies have shown that the earlier cancer is diagnosed, the higher the
chance of effective treatment. Screening methods, such as mammography for breast cancer,
colonoscopy for colorectal cancer, and Pap smears for cervical cancer, are widely recognized in
developed countries. In addition, modern research highlights the importance of artificial
intelligence, radiomics, and biomarkers in enhancing diagnostic accuracy. Studies by the World
Health Organization and the American Cancer Society emphasize that countries with established
screening programs have significantly reduced mortality rates. Scientific literature also points to
the potential of genetic and molecular tests in the early detection and personalized treatment of
cancer.
Methodology
This article is based on the analysis of scientific literature, WHO reports, and current clinical
guidelines related to oncology. Information was obtained from reliable sources such as PubMed,
Elsevier, and WHO databases. Data on commonly used laboratory tests and the effectiveness of
early cancer detection methods were summarized. Additionally, the article presents general
clinical approaches, including modern diagnostic techniques, screening strategies, and laboratory
testing, aimed at improving early diagnosis and patient management.
https://ijmri.de/index.php/jmsi
volume 4, issue 4, 2025
39
Analysis and Results
Laboratory diagnostics play a central role in the early detection and monitoring of oncological
diseases. Tumor markers such as CA-125, PSA, CEA, and AFP are used in clinical practice to
detect specific types of cancer and evaluate treatment response. Molecular and genetic testing
enables the identification of mutations (e.g., BRCA1/2, EGFR, KRAS) that guide targeted
therapy
decisions.
Advances in technologies like real-time PCR, next-generation sequencing (NGS), liquid biopsy,
and mass spectrometry have significantly increased diagnostic accuracy. These methods allow
non-invasive and early detection of malignancies with minimal risk to the patient.
Furthermore, immunological tests, including immunophenotyping and flow cytometry, are
especially valuable in diagnosing hematological cancers. Bone marrow biopsies and cytogenetic
studies provide comprehensive information about disease progression and prognosis.
Results from various studies show that integrating laboratory diagnostics into oncology care
increases survival rates and improves overall treatment planning. Accurate and timely testing not
only helps in confirming diagnosis but also assists in predicting disease recurrence and tailoring
personalized treatment plans.
Conclusion and Recommendations
The fight against oncological diseases requires an integrated and evidence-based approach.
Among the most critical components is the role of laboratory diagnostics, which allows for early
detection, effective monitoring, and personalized treatment planning. The development of
molecular-genetic and immunological testing has expanded diagnostic capabilities and increased
accuracy.
To
improve
outcomes,
it
is
necessary
to:
- Expand access to laboratory testing and modern diagnostic tools, especially in remote regions;
- Train specialists in the latest laboratory techniques and interpretation methods;
- Implement national cancer screening programs based on evidence-based guidelines;
- Promote public awareness regarding the importance of regular check-ups and cancer prevention.
Through early diagnosis and a strong laboratory infrastructure, it is possible to significantly
reduce cancer-related mortality and improve the quality of life for patients.
References
1. World Health Organization. Cancer fact sheets. https://www.who.int/news-room/fact-
sheets/detail/cancer
2. American Cancer Society. Cancer Statistics, 2023. https://www.cancer.org
3. Jemal A, et al. Global cancer statistics. CA: A Cancer Journal for Clinicians.
4. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2023. CA Cancer J Clin.
5. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell.
7. McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory
https://ijmri.de/index.php/jmsi
volume 4, issue 4, 2025
40
Methods.
8. Ferri FF. Ferri’s Clinical Advisor. Elsevier Health Sciences.
9. National Cancer Institute. Cancer Screening Overview. https://www.cancer.gov
10. European Society for Medical Oncology (ESMO) Guidelines. https://www.esmo.org
